Larot, Launcelot A.
HRN: 24-69-06 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/14/2024
03/21/2024
IV
500mg
Q8
T/c Small Bowel Obstruction ETBD
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes